Underestimating Natural Immunity

 

The rates of Covid-19 infection are falling fast and vaccines are getting much of the deserved credit. But what about natural immunity? The once-revered and now embattled Dr. Anthony Fauci told us months ago that we had to have vaccination rates of 70 to 85% before we would ever reach “herd immunity.” But there was never any mention of the importance of natural immunity.

Dr. Marty Makary, professor of medicine at Johns Hopkins School of Medicine, has been an outspoken critic of this lack of accounting for the impact of natural immunity. I wrote of this three months ago in a post called Herd Immunity is Near. Now he brings us up to date on our progress in a recent Op-ed in The Wall Street Journal.

Dr. Makary says today some 80 to 85% of Americans are immune to the virus. More than 64% have received at least one vaccine shot and, of those who haven’t, roughly half have natural immunity due to prior infection. What’s more, this natural immunity is effective and durable, and public health officials should pay it heed.

Although only about 10% of Americans have had confirmed positive Covid tests, four to six times as many have likely had the infection. This data comes from a February study in Nature which used antibody screenings in late summer 2020 to estimate there had been seven times as many actual cases as confirmed cases. A similar study, by the University of Albany and New York State Department of Health, revealed that by the end of March 2020 – the first month of New York’s pandemic – 23% of the city’s population had antibodies. This number certainly grew exponentially as the pandemic spread.

This means that with more than 8 of 10 adults protected from either contracting or transmitting the virus, it can’t readily propagate by jumping around in the population. Dr. Makary says this is the definition of “herd immunity” – broadly defined on the Johns Hopkins Covid information webpage as “when most of a population is immune.”

The proof of this is the declining rates of infection and hospitalization all across the nation. In Los Angeles, 45% of city residents were found to have antibodies in February. Once vaccines were introduced, the seven-day average of daily Covid cases fell from a peak of more than 15,000 on January 11 to 253 four months later, even as people became more mobile. This dramatic drop in rates can’t be accounted for by vaccination rates alone, which were less than 50% at the time.

Some are concerned that virus variants could change all this. But none of the hundreds of variants observed so far have evaded either natural or vaccinated immunity with the three vaccines authorized in the U.S.

Should previously infected individuals get vaccinated?

Dr. Makary says healthy patients with natural immunity need get only one shot, and even that may not be necessary. It is possible one shot will increase the longevity of the natural immunity. A University of Pennsylvania study of people previously infected with Covid found a single vaccine dose triggered a strong immune response, but a second dose had no appreciable increased response. Another study by New York’s Mount Sinai School of Medicine concluded “the antibody response to the first vaccine dose in individuals with pre-existing immunity is equal to or even exceeds the titers found in never-infected individuals after the second dose.”

Understanding the power and significance of natural immunity allows health officials to make sound, scientific recommendations on public health policy. Dr. Makary summarizes his opinion as follows: “Dr. Fauci said last Aug. 13 that when you have fewer than 10 cases per 100,000, “you should be able to open up safely and clearly.” The U.S. reached that point in mid-May. It’s time to stop the fear mongering and level with the public about the incredible capabilities of both modern medical research and the human body’s immune system.”

The Politics of Vaccination Hesitancy

 

Political ideology may be influencing your decision regarding vaccination. That’s the conclusion one easily makes when reviewing surveys regarding vaccination opinions.

According to the Kaiser Family Foundation, Democrats are more likely than Republicans to get the Covid-19 vaccine. When I first heard this, I was surprised since the vaccines were developed under the Republican administration of President Trump. But repeated surveys have confirmed this finding and it remains true today.

William A. Galston, columnist for The Wall Street Journal, tells us more than 80% of Democrats have already received at least one shot, compared with 49% of Republicans. Twenty-seven percent of Republicans say that they won’t get vaccinated under any circumstances, and an additional 9% will do so only if required. That means a solid 36% of Republicans are opposed to the Covid-19 vaccines.

The election results of 2020 would seem to predict vaccination rates across the nation. President Biden carried all 20 states with the highest vaccination rates while Trump carried 17 of the 20 states with the lowest rates of vaccination.

How do you explain these findings?

You might think the opposite of these findings would be true. In addition to the fact the vaccines were developed under a Republican administration, it’s also true that Republicans tend to be older than Democrats. While older Americans are getting vaccinated, the rate of Republicans overall is about the same as 18-to 29-year-olds. Democrats, on the other hand, are receiving shots at the rate of Americans 65 years and older.

Some other demographics are also puzzling. Eighty-one percent of Republicans are white, compared with 59% of Democrats. White Americans are getting vaccinated at higher rates than blacks and Hispanics, who comprise 32% of Democrats but only 9% of Republicans. All things being considered, you would expect Republicans should be getting vaccinated at rates much higher than Democrats. But the opposite is true.

Galston blames these findings on other demographic differences. He says white evangelical Protestants make up one-third of the Republican Party, compared with only 6% of Democrats. He says these white evangelicals get vaccinated at a rate well below the national average. He also says those with college degrees get vaccinated more than those without degrees. Only 30% of Democrats supposedly don’t have college degrees while 57% of Republicans didn’t graduate from college. If these statistics are true, there has been a radical makeover of the Republican and Democratic parties in my lifetime.

Galston gives three hypotheses to explain the differences in Republican v. Democratic vaccination rates:

  • Many Republicans are libertarians – those who oppose government control in any form. To these people, anything the government advocates makes them suspicious. In a survey that asked whether vaccination is a “personal choice” or “part of everyone’s responsibility to protect the health of others,” 71% of Republicans saw it as a personal choice compared with 27% of Democrats.
  • Republicans are populists – who bristle at what they see as elite condescension toward ordinary citizens. Despite the reassurances of medical experts that the vaccines are safe, many Republicans wonder how they can be sure since the vaccines were developed faster than usual.
  • White evangelical Protestants distrust science – Galston says for more than a century, these people have had a tense relationship with modern science, which they see as challenging core tenants of their faith. They are less likely than other Americans to take “follow the science” as their benchmark.

 

What do you believe?

Is Galston correct or way off base? It is certainly true that libertarians tend to favor the Republican Party and also tend to oppose government intrusion into their lives. Perhaps some oppose anything the government favors. But would they put their own health at risk over these differences? Maybe. Many Republicans also detest elite condescension – who wouldn’t? But when your personal health is at stake, it’s a very personal matter. As to the “tense” relationship of white protestants to science, this is perhaps the least credible explanation of all. This sounds like elite condescension to explain differences of opinion on creation v. evolution.

Fortunately, we all still have the choice to be vaccinated or not. I would hope that a careful review of the science, and the risks v. benefits of the vaccines, would be the driving influence on whether or not people get vaccinated – not political ideology. We still live in a free country and the choice is everyone’s to make.

Let me know what you believe – and your reasons for accepting or rejecting the vaccines.

 

Alzheimer’s Hope Arrives

 

The Food and Drug Administration finally got it right. The FDA and other government agencies involved in healthcare have had their share of failures in the last year or more, but now there’s hope for Americans suffering with Alzheimer’s disease.

In an earlier post, Risk v. Benefits in Drug Treatments, I criticized the FDA for dragging their heels on approving Biogen’s new Alzheimer’s treatment drug, aducanumab.  Now the FDA has approved the drug, the first treatment shown to slow cognitive decline, giving hope to millions. I doubt my post had anything to do with this change, but credit FDA Acting Commissioner Janet Woodcock for resisting the pressure from those on the left who have campaigned against the drug.

The Wall Street Journal editorial board says aducanumab’s twisted path to approval illustrates the challenges of drug development. Hundreds of experimental Alzheimer’s treatments have failed in clinical trials over decades. While some approved drugs can temporarily mitigate behavioral and cognitive symptoms, none before aducanumab had shown an impact on disease progression.

The cause of Alzheimer’s is still elusive but its hallmark is amyloid plaques and tau tangles in the brain, which usually begins long before symptoms become apparent. Many scientists believe removing amyloid could slow disease progression. This is how aducanumab works, by clearing amyloid. A high dose of the drug in a late-stage trial removed 71% of the amyloid buildup after 18 months.

Earlier trials of aducanumab failed, but post-trial analysis suggested the termination of the trials was premature. Significant benefits were discovered when higher doses were used. The higher doses were also needed for a longer time than initially tried.

The FDA worked with Biogen to analyze the data, which the FDA described as “exceptionally persuasive.” But an outside advisory panel disagreed, though none of its members actively treated Alzheimer’s patients. The panel accused Biogen of massaging the data. Activists on the left attacked the FDA for collaborating with Biogen. They claimed the FDA would be lowering its standards and compromising its objectivity if it approved the drug.

Perhaps this opposition from the left was related to TDS – Trump Derangement Syndrome. President Trump’s Operation Warp Speed made possible the development of three Covid vaccines in less than a year by encouraging collaboration between the FDA and pharmaceutical companies. Give credit to the Biden administration’s FDA for ignoring those on the left who would try to stifle this game-changing new drug development.

The WSJ editorial board says many of the critics seem to object to the cost more than the effectiveness. New blood tests can identify the disease years before signs of cognitive decline, so the potential patient pool may soon expand. But with Alzheimer’s costs in the U.S. estimated at $277 billion a year, a drug that can mitigate this horrible disease is well worth the investment.